[e-mail]

Access Pharma: MuGard, Pipeline Make for Appealing Acquisition Possibilities

Do you realize Macrochem was controlled by......the Access CEO and resident clown, Jeff Davis? Talk about self dealing. You should note that when you use Macrochem holders selling as your excuse for weakness.

Your examples of Facet and Cougar as proof Access will be acquired for rich money is misplaced. Havrilla's ass this thing will be acquired for $200-240M.

PDL BioPharma: High Dividend Biotech Stock

FACT will not pay dividends.

You missed the negative that the royalty flows to PDLI have an expiration, at expiration, no more dividend, no more company, they liquidate. You have to factor this into your math.